Open
Accelerate Program for Quebec Emerging Companies
Support for Therapeutics, Med-Tech and Digital Health innovators
Record updated
- Funding available
- Varies by project
- Deadline
- Unspecified
- Location
- Quebec, Canada
- Who can apply
- Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.
- See full eligibility
Overview
Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.
At a glance
Funding available
Varies by project
Eligible candidates
- Location
- Quebec
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- Startups
- Legal structures
- For-profit business
Start applying for this program
Take a practical assessment to gain a clear understanding of how well this program aligns with your specific needs and long-term goals.
Availability timeline
2022
Periods: 1
Eligibility
Who is eligible?
Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.
Eligible expenses
adMare provides opportunities for collaborations that transform academic research into new therapeutic products and bio-innovation companies. The eligible projects focus on early-stage technology development and company-building in the life sciences sector.
- Collaboration with researchers to translate leading academic research into therapeutics and health innovations.
- Identification and advancement of pre-clinical technologies addressing unmet medical needs.
- Creation of new Canadian life sciences companies by partnering with scientists and entrepreneurs.
- Development of a business case to attract private sector investment.
- Support for growth of existing life sciences companies through shared expertise and investment capital.
How to apply
- Step 1: Identify opportunities
- Implications: Assess potential therapeutic opportunities discovered by Canadian researchers that have commercial potential.
- Step 2: Develop & advance technologies
- Implications: Collaborate with founding researchers to progress the discovery towards the next development milestone and investment readiness. Dedicate professional R&D resources and infrastructure to generate valuable data and IP.
- Step 3: Build partnerships
- Implications: Engage partners from academia, industry, patient foundations, the investment community, and key opinion leaders to support the advancement of technologies and creation of new companies.
- Step 4: Assemble a team
- Implications: Work with co-founders to build an experienced management and scientific team to create a compelling business case for investors.
- Step 5: Secure seed investment
- Implications: Evaluate the differentiation, market opportunity, team quality, IP coverage, and potential ROI to secure adMare seed investment that will make the company attractive to private capital.
Selection criteria
The evaluation and selection criteria for projects under this grant focus on ensuring alignment with adMare's strategic investment goals.
- Differentiation and competitive advantage of the technology.
- Market opportunity and potential for growth.
- Quality and experience of the team involved.
- Scope and strength of intellectual property coverage.
- Potential return on investment.
- The impact of an adMare seed investment in building the company to a value inflection point that attracts private capital.
Contacts
Official sources
Frequently Asked Questions about the Accelerate Program for Quebec Emerging Companies Program
What is the Accelerate Program for Quebec Emerging Companies?
Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.
Who is eligible for the Accelerate Program for Quebec Emerging Companies program?
To be eligible for the Accelerate Program for Quebec Emerging Companies program, you must:
The applicant must be an emerging company based in Quebec.
The company must demonstrate innovation in their field.
The application should include a detailed business plan.
What expenses are eligible under Accelerate Program for Quebec Emerging Companies?
adMare provides opportunities for collaborations that transform academic research into new therapeutic products and bio-innovation companies. The eligible projects focus on early-stage technology development and company-building in the life sciences sector.
Collaboration with researchers to translate leading academic research into therapeutics and health innovations.
Identification and advancement of pre-clinical technologies addressing unmet medical needs.
Creation of new Canadian life sciences companies by partnering with scientists and entrepreneurs.
Development of a business case to attract private sector investment.
Support for growth of existing life sciences companies through shared expertise and investment capital.
Who can I contact for more information about the Accelerate Program for Quebec Emerging Companies?
You can contact adMare Bioinnovations or by phone at 514.375.3334.
Where is the Accelerate Program for Quebec Emerging Companies available?
The Accelerate Program for Quebec Emerging Companies program is available the province of Quebec.
Is the Accelerate Program for Quebec Emerging Companies a grant, loan, or tax credit?
Accelerate Program for Quebec Emerging Companies is a Expert Advice
Who are the financial supporters of the Accelerate Program for Quebec Emerging Companies?
Accelerate Program for Quebec Emerging Companies is funded by adMare Bioinnovations